YiRui Bio: YiRui Chuangtou and Zhu Hai plan to reduce their holdings in the company by 0.88% and 1.87% respectively.

Erwei Biotechnology announced that its controlling shareholder, Erwei Entrepreneurial Investment Co., Ltd., plans to reduce its holdings by no more than 3.5312 million shares, accounting for 0.88% of the company's total share capital; the actual controller, Zhu Hai, plans to reduce his holdings by no more than 7.5214 million shares, accounting for 1.87% of the company's total share capital. The reduction will be made through centralized bidding or block trading, and will take place from July 28, 2025 to October 27, 2025. The reason for the reduction is the company's own capital needs.